Cisatracurium Besylate Injection
Product Images NDC 70069-161

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Cisatracurium Besylate (NDC 70069-161). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Somerset Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (16bbec4b 027e 470e Aac9 E041bc5e24f5 01)

Chemical structure diagram of Cisatracurium Besylate showing molecular connectivity, including aromatic rings, methoxy groups, quaternary ammonium centers, ester linkages, and a benzenesulfonate counter ion.*

FDA Label Image

Image (16bbec4b 027e 470e Aac9 E041bc5e24f5 02)

A scatter plot chart depicting individual data points comparing changes in heart rate (HR) on the vertical axis and mean arterial pressure (MAP) on the horizontal axis. Both axes range from -60% to +60%, showing variability centered around zero change.*

FDA Label Image

Image (16bbec4b 027e 470e Aac9 E041bc5e24f5 03)

A scatter plot chart showing data points distributed around the origin with axes labeled as MAP (mean arterial pressure) on the horizontal axis and HR (heart rate) on the vertical axis, both ranging from -60% to +60%.*

FDA Label Image

Container Label (16bbec4b 027e 470e Aac9 E041bc5e24f5 04)

Label for Cisatracurium Besylate Injection, USP 2 mg/mL (20 mg/10 mL) multiple-dose vial by Somerset Therapeutics, LLC. Contains 0.9% benzyl alcohol as preservative. Includes warnings for its paralyzing effect and respiratory arrest risk. Provides storage instructions and manufacturing details.*

FDA Label Image

Carton Label (pack of 1)

The label for Cisatracurium Besylate Injection, USP, 2 mg/mL (20 mg/10 mL) by Somerset Therapeutics LLC is shown. It includes warnings about the drug being a paralyzing agent causing respiratory arrest and requires facilities for artificial respiration. The label details product composition, storage instructions, and shows a barcode. The label is for a 10 mL multiple-dose vial and includes manufacturer information.*

FDA Label Image

Carton (pack of 10 vials)

Label for Cisatracurium Besylate Injection, USP, 2 mg/mL strength (20 mg/10 mL). The label warns of the drug as a paralyzing agent and includes preservation information about 0.9% benzyl alcohol. It indicates the product is manufactured for Somerset Therapeutics, LLC, with storage instructions and a 10x10 mL multiple-dose vial packaging.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.